$VEEV
VEEVA SYSTEMS INC

2014 Q2 Form 10-Q Financial Statement

#000119312514228721 Filed on June 06, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q2
Revenue $66.72M $62.80M $42.79M
YoY Change 55.93% 57.84% 74.58%
Cost Of Revenue $25.95M $24.36M $17.71M
YoY Change 46.54% 45.33% 56.04%
Gross Profit $40.77M $38.45M $25.08M
YoY Change 62.57% 66.96% 90.57%
Gross Profit Margin 61.11% 61.22% 58.61%
Selling, General & Admin $19.22M $19.28M $11.38M
YoY Change 68.93% 114.86% 113.09%
% of Gross Profit 47.15% 50.15% 45.37%
Research & Development $8.992M $7.858M $5.527M
YoY Change 62.69% 67.48% 80.92%
% of Gross Profit 22.05% 20.44% 22.04%
Depreciation & Amortization $300.0K $800.0K $200.0K
YoY Change 50.0% 166.67% 0.0%
% of Gross Profit 0.74% 2.08% 0.8%
Operating Expenses $28.21M $27.14M $16.91M
YoY Change 66.89% 98.59% 101.38%
Operating Profit $12.56M $11.31M $8.173M
YoY Change 53.64% 20.79% 71.52%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$30.00K -$365.0K -$499.0K
YoY Change -93.99% -39.47% -5090.0%
Pretax Income $12.53M $10.94M $7.674M
YoY Change 63.24% 24.93% 60.71%
Income Tax $5.306M $4.696M $2.829M
% Of Pretax Income 42.36% 42.91% 36.86%
Net Earnings $7.221M $6.247M $4.845M
YoY Change 49.04% 9.9% 56.14%
Net Earnings / Revenue 10.82% 9.95% 11.32%
Basic Earnings Per Share $0.06 $0.05 $0.04
Diluted Earnings Per Share $0.05 $0.04 $0.03
COMMON SHARES
Basic Shares Outstanding 123.9M 122.6M 21.61M
Diluted Shares Outstanding 142.8M 143.2M 32.99M

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $345.5M $288.1M $59.20M
YoY Change 483.61%
Cash & Equivalents $188.9M $262.5M $44.35M
Short-Term Investments $156.6M $25.60M $14.80M
Other Short-Term Assets $5.500M $5.092M $2.800M
YoY Change 96.43% 364.18%
Inventory
Prepaid Expenses
Receivables $61.22M $58.43M $37.90M
Other Receivables $4.500M $0.00 $0.00
Total Short-Term Assets $418.8M $353.7M $99.90M
YoY Change 319.2% 307.1%
LONG-TERM ASSETS
Property, Plant & Equipment $2.494M $2.445M $1.500M
YoY Change 66.27% 77.3%
Goodwill $4.850M $4.850M $4.850M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.212M $1.145M $1.200M
YoY Change 1.0% 70.64%
Total Long-Term Assets $16.34M $16.58M $3.500M
YoY Change 366.91% 465.73%
TOTAL ASSETS
Total Short-Term Assets $418.8M $353.7M $99.90M
Total Long-Term Assets $16.34M $16.58M $3.500M
Total Assets $435.1M $370.3M $103.4M
YoY Change 320.82% 312.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.098M $2.117M $1.700M
YoY Change 82.24% -36.62%
Accrued Expenses $7.876M $7.931M $12.20M
YoY Change -35.44% 13.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $101.2M $86.62M $61.80M
YoY Change 63.8% 59.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.909M $1.897M $1.200M
YoY Change 59.08% 68.77%
Total Long-Term Liabilities $1.909M $1.897M $1.200M
YoY Change 59.08% 68.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $101.2M $86.62M $61.80M
Total Long-Term Liabilities $1.909M $1.897M $1.200M
Total Liabilities $104.8M $90.21M $63.40M
YoY Change 65.36% 61.51%
SHAREHOLDERS EQUITY
Retained Earnings $55.76M $48.54M
YoY Change 94.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $330.3M $280.1M $39.90M
YoY Change
Total Liabilities & Shareholders Equity $435.1M $370.3M $103.4M
YoY Change 320.82% 312.28%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q2
OPERATING ACTIVITIES
Net Income $7.221M $6.247M $4.845M
YoY Change 49.04% 9.9% 56.14%
Depreciation, Depletion And Amortization $300.0K $800.0K $200.0K
YoY Change 50.0% 166.67% 0.0%
Cash From Operating Activities $18.10M $16.30M $13.00M
YoY Change 39.23% 132.86% 80.56%
INVESTING ACTIVITIES
Capital Expenditures $299.0K -$400.0K $217.0K
YoY Change 37.79% 33.33% -208.5%
Acquisitions
YoY Change
Other Investing Activities -$131.3M -$9.500M -$600.0K
YoY Change 21783.33% 106.52% 200.0%
Cash From Investing Activities -$131.8M -$9.900M -$800.0K
YoY Change 16375.0% 106.25% 60.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.10M -1.000M 300.0K
YoY Change 13266.67% -1100.0% 200.0%
NET CHANGE
Cash From Operating Activities 18.10M 16.30M 13.00M
Cash From Investing Activities -131.8M -9.900M -800.0K
Cash From Financing Activities 40.10M -1.000M 300.0K
Net Change In Cash -73.60M 5.400M 12.50M
YoY Change -688.8% 134.78% 83.82%
FREE CASH FLOW
Cash From Operating Activities $18.10M $16.30M $13.00M
Capital Expenditures $299.0K -$400.0K $217.0K
Free Cash Flow $17.80M $16.70M $12.78M
YoY Change 39.26% 128.77% 72.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44354000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4362659 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.73
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24178374 shares
CY2014Q2 us-gaap Share Price
SharePrice
19.21
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.67
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.80
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
22566905 shares
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7876000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2210000
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1713000
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
274491000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6722000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3098000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1990000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
317000
CY2014Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1448000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
615000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
101231000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
31000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
7000
CY2014Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14519000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1909000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
330286000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
494000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
55763000
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
74872000
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1433000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
435124000
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1698000
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
866000
CY2014Q2 us-gaap Liabilities
Liabilities
104838000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
305000
CY2014Q2 us-gaap Assets
Assets
435124000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1406000
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
64836000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
65000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
418782000
CY2014Q2 us-gaap Goodwill
Goodwill
4850000
CY2014Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
156548000
CY2014Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4494000
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1212000
CY2014Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
156608000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
454000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188888000
CY2014Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1645000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61217000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1650000
CY2014Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
400000
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4207000
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6141000
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
80302465
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7574000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
379453926
CY2014Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3093000
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5500000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1579000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
355302503
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1154000
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2075000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1239000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2494000
CY2014Q2 veev Liability Associated With Potential For Share Repurchases Due To Early Exercise Provisions
LiabilityAssociatedWithPotentialForShareRepurchasesDueToEarlyExerciseProvisions
400000
CY2014Q2 veev Unrecognized Compensation Cost Related To Nonvested Share Based Compensation Arrangements
UnrecognizedCompensationCostRelatedToNonvestedShareBasedCompensationArrangements
40000000
CY2014Q2 veev Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
11000
CY2014Q2 veev Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
71000
CY2014Q2 veev Available For Sale Securities Debt Maturities Greater Than One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesGreaterThanOneYearFairValue
91772000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31890000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.22
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
25424437 shares
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7931000
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1394000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
231534000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2117000
CY2014Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1249000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
86617000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
19000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8750000
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1897000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
280096000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48542000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
67380000
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1023000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
370308000
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1698000
CY2014Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
439000
CY2014Q1 us-gaap Liabilities
Liabilities
90212000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
17667000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
353732000
CY2014Q1 us-gaap Goodwill
Goodwill
4850000
CY2014Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
25610000
CY2014Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1389000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1145000
CY2014Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
25625000
CY2014Q1 us-gaap Assets
Assets
370308000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
262507000
CY2014Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1585000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
58433000
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3839000
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6551000
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7574000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
726649586
CY2014Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2834000
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
3703000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2075000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2445000
CY2014Q1 veev Liability Associated With Potential For Share Repurchases Due To Early Exercise Provisions
LiabilityAssociatedWithPotentialForShareRepurchasesDueToEarlyExerciseProvisions
500000
CY2014Q1 veev Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
1000
CY2014Q1 veev Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
16000
CY2014Q1 veev Available For Sale Securities Debt Maturities Greater Than One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesGreaterThanOneYearFairValue
7958000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2014 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32988000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.369 pure
CY2013Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
13023000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.38
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21610000 shares
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
91000
CY2013Q2 us-gaap Revenues
Revenues
42788000
CY2013Q2 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
100000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4848000
CY2013Q2 us-gaap Gross Profit
GrossProfit
25079000
CY2013Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1357000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7674000
CY2013Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18000
CY2013Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
14851000
CY2013Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
2945000
CY2013Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
528000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8173000
CY2013Q2 us-gaap Subscription Revenue
SubscriptionRevenue
27937000
CY2013Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
888000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
4845000
CY2013Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-89000
CY2013Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
217000
CY2013Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
212000
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
CY2013Q2 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
700000
CY2013Q2 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0
CY2013Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
499000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3717000
CY2013Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
274000
CY2013Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5456000
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
267000
CY2013Q2 us-gaap Technology Services Costs
TechnologyServicesCosts
10759000
CY2013Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12464000
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7662000
CY2013Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-833000
CY2013Q2 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
6950000
CY2013Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4947000
CY2013Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-393000
CY2013Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1702000
CY2013Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
104000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
17709000
CY2013Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5527000
CY2013Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
231000
CY2013Q2 us-gaap Depreciation
Depreciation
200000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
735000
CY2013Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
500000
CY2013Q2 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
253000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
16906000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2829000
CY2013Q2 veev Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
153000
CY2013Q2 veev Proceeds From Stock Options Early Exercised
ProceedsFromStockOptionsEarlyExercised
43000
CY2013Q2 veev Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
926000
CY2014Q2 dei Trading Symbol
TradingSymbol
VEEV
CY2014Q2 dei Entity Registrant Name
EntityRegistrantName
VEEVA SYSTEMS INC
CY2014Q2 dei Amendment Flag
AmendmentFlag
false
CY2014Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2014Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2014Q2 dei Document Type
DocumentType
10-Q
CY2014Q2 dei Document Period End Date
DocumentPeriodEndDate
2014-04-30
CY2014Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001393052
CY2014Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2014Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142849000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.48
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.424 pure
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
32.26
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
18130000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.47
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.49
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
300000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123902000 shares
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2014Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1392113 shares
CY2014Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Certain Risks and Concentrations of Credit Risk</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Our revenues are derived from subscription services and professional services delivered primarily to the pharmaceutical and life sciences industry. We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact our operating results.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Our financial instruments that are exposed to concentration of credit risk consist primarily of cash and cash equivalents and trade accounts receivable. We primarily maintain cash at two financial institutions, for which our deposits exceed federally insured limits.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> We do not require collateral from our customers and generally require payment within 30 to 60 days of billing. We periodically evaluate the collectibility of our accounts receivable and provide an allowance for doubtful accounts as necessary, based on historical experience. Historically, such losses have not been material.</p> </div>
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
28000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
153950 shares
CY2014Q2 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the condensed consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Significant items subject to such estimates and assumptions include, but are not limited to:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the best estimate of selling price of the deliverables included in multiple-deliverable revenue arrangements;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the realizability of deferred income tax assets;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the fair value of our stock-based awards; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the capitalization and estimated useful life of internal-use software development costs.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> As future events cannot be determined with precision, actual results could differ significantly from those estimates.</p> </div>
CY2014Q2 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Deferred Revenue</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Deferred revenue includes amounts billed to customers for which the revenue recognition criteria have not been met. The majority of deferred revenue primarily consists of billings or payments received in advance of revenue recognition from our subscription services described above and is recognized as the revenue recognition criteria are met. We generally invoice our customers in annual, quarterly or monthly installments for the subscription services, which are typically one year or less. Accordingly, the deferred revenue balance does not generally represent the total contract value of a subscription arrangement. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current deferred revenue.</p> </div>
CY2014Q2 us-gaap Revenues
Revenues
66721000
CY2014Q2 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
200000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7233000
CY2014Q2 us-gaap Gross Profit
GrossProfit
40771000
CY2014Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
135116000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12527000
CY2014Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
69000
CY2014Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
685000
CY2014Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
18200000
CY2014Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
3918000
CY2014Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1861000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
12557000
CY2014Q2 us-gaap Payments For Software
PaymentsForSoftware
220000
CY2014Q2 us-gaap Subscription Revenue
SubscriptionRevenue
48521000
CY2014Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2812000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
7221000
CY2014Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-312000
CY2014Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-34000
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3295000
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
4379000
CY2014Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34479000
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
299000
CY2014Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
3000
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
46000
CY2014Q2 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
3867000
CY2014Q2 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2014Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
30000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6408000
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
40058000
CY2014Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7492000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
30842309
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
930000
CY2014Q2 us-gaap Technology Services Costs
TechnologyServicesCosts
13910000
CY2014Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-73619000
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12814000
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-131771000
CY2014Q2 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
12040000
CY2014Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5318000
CY2014Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2678000
CY2014Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
912000
CY2014Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
12000
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
25950000
CY2014Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
300000
CY2014Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
34994000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8992000
CY2014Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
685000
CY2014Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4379000
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2014Q2 us-gaap Depreciation
Depreciation
300000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3256000
CY2014Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
700000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
28214000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5306000
CY2014Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-36000
CY2014Q2 veev Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
119000
CY2014Q2 veev Share Based Compensation Arrangement By Share Based Payment Award Unvested Stock Options Awards Weighted Average Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedStockOptionsAwardsWeightedAveragePeriod
P5Y
CY2014Q2 veev Increase Decrease In Effective Income Tax Rate Continuing Operations
IncreaseDecreaseInEffectiveIncomeTaxRateContinuingOperations
0.055 pure
CY2014Q2 veev Initial Public Offering Costs Incurred But Not Yet Paid
InitialPublicOfferingCostsIncurredButNotYetPaid
515000
CY2014Q2 veev Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
7128000

Files In Submission

Name View Source Status
0001193125-14-228721-index-headers.html Edgar Link pending
0001193125-14-228721-index.html Edgar Link pending
0001193125-14-228721.txt Edgar Link pending
0001193125-14-228721-xbrl.zip Edgar Link pending
d707842d10q.htm Edgar Link pending
d707842dex101.htm Edgar Link pending
d707842dex311.htm Edgar Link pending
d707842dex312.htm Edgar Link pending
d707842dex321.htm Edgar Link pending
d707842dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g707842g80j58.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
veev-20140430.xml Edgar Link completed
veev-20140430.xsd Edgar Link pending
veev-20140430_cal.xml Edgar Link unprocessable
veev-20140430_def.xml Edgar Link unprocessable
veev-20140430_lab.xml Edgar Link unprocessable
veev-20140430_pre.xml Edgar Link unprocessable